Alpha Profiles · Company Profile

Vera Therapeutics, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/vera-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: VERA
Verification: Partially verified
Last reviewed: 2026-09-17T04:45:50.860268+00:00

Overview

Alpha's canonical identity and public leadership record for Vera Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

8 public records

David Johnson

Chief Operating Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014002Apr 9, 2026

Jane Wright-Mitchell

Chief Legal Officer and Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014002Apr 9, 2026

Marshall Fordyce, M.D.

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014002Apr 9, 2026

Matthew Skelton

Chief Commercial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014002Apr 9, 2026

Robert Brenner, M.D.

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014002Apr 9, 2026

Sean Grant

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014002Apr 9, 2026

Shane Grant

Chief Financial Officer

State: confirmed
Effective: From Apr 9, 2026
Confidence: 94%
Evidence: VERA DEF 14A executive officersApr 9, 2026

William Turner

Chief Regulatory Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014002Apr 9, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 17, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.